Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-01

Clinical Trial Update: A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing metformin and glybenclamide for gestational diabetes mellitus has completed; the study assessed comparative efficacy and safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucophage (metformin)
  • Glybenclamide (glybenclamide)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Gestational Diabetes Mellitus | Phase 4 | Status: COMPLETED